Global Health Valuation
| GLH Stock | 0.14 0.01 7.69% |
Global Health seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Global Health from evaluating the firm fundamentals such as Return On Equity of -13.59, return on asset of -0.25, and Current Valuation of 6.94 M as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 2.6633 | Enterprise Value 6.9 M | Enterprise Value Ebitda (4.09) | Price Sales 0.9185 | Enterprise Value Revenue 0.8547 |
Overvalued
Today
Please note that Global Health's price fluctuation is out of control at this time. Calculation of the real value of Global Health is based on 3 months time horizon. Increasing Global Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Global Health's intrinsic value may or may not be the same as its current market price of 0.14, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.14 | Real 0.12 | Hype 0.14 | Naive 0.14 |
The intrinsic value of Global Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Global Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Global Health helps investors to forecast how Global stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Global Health more accurately as focusing exclusively on Global Health's fundamentals will not take into account other important factors: Global Health Cash |
|
Global Health Total Value Analysis
Global Health is currently forecasted to have takeover price of 6.94 M with market capitalization of 7.95 M, debt of 1.03 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Global Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.94 M | 7.95 M | 1.03 M |
Global Health Investor Information
About 78.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.02. Global Health last dividend was issued on the 1st of March 2017. The entity had 1:15 split on the 3rd of December 2012. Based on the key indicators obtained from Global Health's historical financial statements, Global Health is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Global Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Global Health has an asset utilization ratio of 264.01 percent. This implies that the Company is making USD2.64 for each dollar of assets. An increasing asset utilization means that Global Health is more efficient with each dollar of assets it utilizes for everyday operations.Global Health Ownership Allocation
Global Health has a total of 58.05 Million outstanding shares. Global Health retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 77.53 (percent) of Global Health outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Global Health Profitability Analysis
The company reported the revenue of 8.12 M. Net Loss for the year was (1.31 M) with profit before overhead, payroll, taxes, and interest of 511.21 K.About Global Health Valuation
The stock valuation mechanism determines Global Health's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Global Health based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Global Health. We calculate exposure to Global Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Global Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -689.9 K | -655.4 K |
Additional Tools for Global Stock Analysis
When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.